Income Statement Devonshire Industries Limited

Stocks

DEVON.BH

BMG2743K1062

Commodity Chemicals

End-of-day quote BERMUDA STOCK EXCHANGE LTD 2026-08-17			5-day change	1st Jan Change
4.300 ^BMD	-.--%		-.--%	-33.85%

09-17	Devonshire Industries Limited Reports Earnings Results for the Full Year Ended March 31, 2026	CI
25-09-08	Devonshire Industries Limited Reports Earnings Results for the Full Year Ended March 31, 2025	CI

c8d1ab3d51406c228a02d8dcfcf7.W79XNK8gaq6_hDCFy2iDQOFLSOgTz7vEAe32z4dEqnk.GIwADeNlAt_lqVzIsQvzOoA-I51Z4v6GbZXAq7IW3i4Qjg5BzGIe9OezBA

Published financial data: DEVONSHIRE INDUSTRIES LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2022 (BMD)	2023 (BMD)	2024 (BMD)	2025 (BMD)	2026 (BMD)
Revenues	2.62M	2.78M	2.83M	2.95M	2.6M
Total Revenues	2.62M	2.78M	2.83M	2.95M	2.6M
Cost of Goods Sold, Total	1.55M	1.69M	1.61M	1.66M	1.5M
Gross Profit	1.07M	1.09M	1.22M	1.3M	1.1M
Selling General & Admin Expenses, Total	857K	846K	835K	898K	942K
Provision for Bad Debts	477	4.9K	-10.3K	1.15K	-1.57K
Other Operating Expenses	81.11K	90.35K	88.34K	88.24K	92.63K
Other Operating Expenses, Total	938K	942K	913K	987K	1.03M
Operating Income	130K	149K	310K	308K	69.64K
Interest Expense, Total	-	-	-	-	-
Net Interest Expenses	-	-	-	-	-
Currency Exchange Gains (Loss)	-4.68K	-6.25K	-4.76K	-5.7K	-3.62K
Other Non Operating Income (Expenses)	15.08K	23.64K	12.96K	18.82K	16.38K
EBT, Excl. Unusual Items	141K	167K	318K	321K	82.4K
Asset Writedown	-	-	-	-	-
EBT, Incl. Unusual Items	141K	167K	318K	321K	82.4K
Earnings From Continuing Operations	141K	167K	318K	321K	82.4K
Net Income to Company	141K	167K	318K	321K	82.4K
Net Income - (IS)	141K	167K	318K	321K	82.4K
Net Income to Common Incl Extra Items	141K	167K	318K	321K	82.4K
Net Income to Common Excl. Extra Items	141K	167K	318K	321K	82.4K
Per Share Items
Net EPS - Basic	0.32	0.38	0.72	0.73	0.19
Basic EPS - Continuing Operations	0.32	0.38	0.72	0.73	0.19
Basic Weighted Average Shares Outstanding	441K	441K	441K	441K	441K
Net EPS - Diluted	0.32	0.38	0.72	0.73	0.19
Diluted EPS - Continuing Operations	0.32	0.38	0.72	0.73	0.19
Diluted Weighted Average Shares Outstanding	441K	441K	441K	441K	441K
Normalized Basic EPS	0.2	0.24	0.45	0.45	0.12
Normalized Diluted EPS	0.2	0.24	0.45	0.45	0.12
Dividend Per Share	0.5	0.5	0.5	0.5	0.5
Payout Ratio	156.84	123.79	137.41	68.01	264.78
Supplemental Items
EBITDA	172K	191K	336K	338K	105K
EBITA	130K	149K	310K	308K	69.64K
EBIT	130K	149K	310K	308K	69.64K
Normalized Net Income	87.94K	104K	199K	201K	51.5K
Supplemental Operating Expense Items
Marketing Expenses	16.42K	12.72K	12.76K	17.19K	22.32K
Selling and Marketing Expenses	307K	278K	280K	304K	301K
General and Administrative Expenses	550K	568K	555K	594K	641K
Research And Development Expense From Footnotes	-	-	-	-	-
Maintenance & Repair Expenses, Total	21.71K	16.48K	13.72K	17.79K	20.25K

Fiscal Period: March	2022 (BMD)	2023 (BMD)	2024 (BMD)	2025 (BMD)	2026 (BMD)
Assets
Cash And Equivalents	664K	640K	639K	521K	527K
Total Cash And Short Term Investments	664K	640K	639K	521K	527K
Accounts Receivable, Total	186K	201K	128K	178K	187K
Total Receivables	186K	201K	128K	178K	187K
Inventory	1.18M	1.34M	1.16M	1.37M	1.07M
Prepaid Expenses	166K	124K	106K	94.99K	119K
Total Current Assets	2.2M	2.31M	2.03M	2.16M	1.9M
Gross Property Plant And Equipment	3.12M	3.09M	3.1M	3.22M	3.27M
Accumulated Depreciation	-2.71M	-2.72M	-2.74M	-2.77M	-2.81M
Net Property Plant And Equipment	405K	373K	359K	445K	463K
Other Intangibles, Total	8.33K	2.68K	0	-	-
Deferred Charges Long-Term	0	0	0	-	-
Other Long-Term Assets, Total	1.5K	1.5K	1.5K	1.5K	1.5K
Total Assets	2.61M	2.69M	2.39M	2.61M	2.36M
Liabilities
Accounts Payable, Total	27.01K	117K	18.56K	86.6K	23.52K
Accrued Expenses, Total	85.4K	109K	89.94K	128K	84.42K
Other Current Liabilities	56.44K	70.3K	20.94K	26.71K	28.22K
Total Current Liabilities	169K	296K	129K	241K	136K
Total Liabilities	169K	296K	129K	241K	136K
Common Stock, Total	221K	221K	221K	221K	221K
Additional Paid In Capital	146K	146K	146K	146K	146K
Retained Earnings	2.08M	2.02M	1.9M	2M	1.86M
Total Common Equity	2.44M	2.39M	2.27M	2.37M	2.23M
Total Equity	2.44M	2.39M	2.27M	2.37M	2.23M
Total Liabilities And Equity	2.61M	2.69M	2.39M	2.61M	2.36M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	441K	441K	441K	441K	441K
ECS Total Common Shares Outstanding	441K	441K	441K	441K	441K
Book Value / Share	5.54	5.41	5.13	5.36	5.05
Tangible Book Value	2.43M	2.39M	2.27M	2.37M	2.23M
Tangible Book Value Per Share	5.52	5.41	5.13	5.36	5.05
Total Debt	0	0	0	0	0
Net Debt	-664K	-640K	-639K	-521K	-527K
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	700K	801K	727K	773K	568K
Inventories - Finished Goods, Total	481K	544K	442K	596K	505K
Land - (BS)	225K	225K	225K	225K	225K
Buildings, Total	805K	805K	805K	899K	899K
Machinery, Total	1.59M	1.56M	1.57M	1.59M	1.63M
Accumulated Allowance for Doubtful Accounts (Supple)	7.16K	12.02K	1.3K	2.46K	664

Fiscal Period: March	2022 (BMD)	2023 (BMD)	2024 (BMD)	2025 (BMD)	2026 (BMD)
Net Income	141K	167K	318K	321K	82.4K
Depreciation & Amortization - CF	41.91K	41.51K	26.77K	30.45K	34.93K
Depreciation & Amortization, Total	41.91K	41.51K	26.77K	30.45K	34.93K
Amortization of Deferred Charges, Total - (CF)	5.65K	5.65K	2.68K	-	-
(Gain) Loss From Sale Of Asset	-	-8K	-	-	-
Asset Writedown & Restructuring Costs	-	-	-	-	-
Provision and Write-off of Bad Debts	-	-	-	-	-
Other Operating Activities, Total	-	-	-	-	-
Change In Accounts Receivable	-42.24K	-14.86K	73.17K	-49.6K	-9.22K
Change In Inventories	46.94K	-161K	180K	-205K	300K
Change In Accounts Payable	28.58K	113K	-172K	109K	-107K
Change in Other Net Operating Assets	-27.17K	41.91K	18.92K	10.56K	-23.63K
Cash from Operations	194K	185K	447K	216K	277K
Capital Expenditure	-26.02K	-10.16K	-12.07K	-116K	-52.8K
Sale of Property, Plant, and Equipment	-	8K	-	-	-
Sale (Purchase) of Intangible assets	-	-	-	-	-
Cash from Investing	-26.02K	-2.16K	-12.07K	-116K	-52.8K
Common Dividends Paid	-221K	-206K	-437K	-218K	-218K
Common & Preferred Stock Dividends Paid	-221K	-206K	-437K	-218K	-218K
Cash from Financing	-221K	-206K	-437K	-218K	-218K
Net Change in Cash	-52.32K	-23.39K	-1.45K	-119K	6.51K
Supplemental Items
Levered Free Cash Flow	109K	124K	316K	-26.35K	188K
Unlevered Free Cash Flow	109K	124K	316K	-26.35K	188K
Change In Net Working Capital	-6.11K	6.24K	-105K	133K	-163K

Fiscal Period: March	2022 (BMD)	2023 (BMD)	2024 (BMD)	2025 (BMD)	2026 (BMD)
Profitability
Return on Assets	3.09	3.52	7.62	7.69	1.75
Return on Total Capital	3.28	3.86	8.31	8.31	1.9
Return On Equity %	5.67	6.89	13.65	13.86	3.59
Return on Common Equity	5.67	6.89	13.65	13.86	3.59
Margin Analysis
Gross Profit Margin %	40.77	39.21	43.21	43.83	42.41
SG&A Margin	32.68	30.42	29.51	30.39	36.23
EBITDA Margin %	6.57	6.85	11.89	11.45	4.02
EBITA Margin %	4.97	5.36	10.94	10.42	2.68
EBIT Margin %	4.97	5.36	10.94	10.42	2.68
Income From Continuing Operations Margin %	5.37	5.99	11.23	10.86	3.17
Net Income Margin %	5.37	5.99	11.23	10.86	3.17
Net Avail. For Common Margin %	5.37	5.99	11.23	10.86	3.17
Normalized Net Income Margin	3.36	3.74	7.02	6.79	1.98
Levered Free Cash Flow Margin	4.16	4.46	11.16	-0.89	7.24
Unlevered Free Cash Flow Margin	4.16	4.46	11.16	-0.89	7.24
Asset Turnover
Asset Turnover	0.99	1.05	1.11	1.18	1.05
Fixed Assets Turnover	6.35	7.15	7.73	7.35	5.73
Receivables Turnover (Average Receivables)	15.87	14.36	17.19	19.34	14.28
Inventory Turnover (Average Inventory)	1.29	1.34	1.28	1.31	1.23
Short Term Liquidity
Current Ratio	13.01	7.79	15.72	8.97	13.95
Quick Ratio	5.03	2.84	5.93	2.9	5.24
Operating Cash Flow to Current Liabilities	1.15	0.62	3.46	0.9	2.04
Days Sales Outstanding (Average Receivables)	22.99	25.41	21.29	18.87	25.56
Days Outstanding Inventory (Average Inventory)	283.16	272.23	285.26	278.17	296.66
Average Days Payable Outstanding	8.36	14.22	17.42	10.29	16.79
Cash Conversion Cycle (Average Days)	297.8	283.42	289.12	286.75	305.44
Long Term Solvency
Total Liabilities / Total Assets	6.46	11.03	5.4	9.24	5.76
EBIT / Interest Expense	-	-	-	-	-
EBITDA / Interest Expense	-	-	-	-	-
(EBITDA - Capex) / Interest Expense	-	-	-	-	-
Net Debt / EBITDA	-3.85	-3.36	-1.9	-1.54	-5.04
Net Debt / (EBITDA - Capex)	-4.54	-3.55	-1.97	-2.35	-10.18
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	2.5	6.14	1.67	4.45	-11.99
Gross Profit, 1 Yr. Growth %	-2.91	2.08	12.05	5.96	-14.84
EBITDA, 1 Yr. Growth %	-37.68	10.71	76.39	0.55	-69.08
EBITA, 1 Yr. Growth %	-42.16	14.45	107.53	-0.59	-77.37
EBIT, 1 Yr. Growth %	-42.16	14.45	107.53	-0.59	-77.37
Earnings From Cont. Operations, 1 Yr. Growth %	-40.69	18.35	90.78	0.98	-74.32
Net Income, 1 Yr. Growth %	-40.69	18.35	90.78	0.98	-74.32
Normalized Net Income, 1 Yr. Growth %	-40.69	18.35	90.78	0.98	-74.32
Diluted EPS Before Extra, 1 Yr. Growth %	-40.69	18.35	90.78	0.98	-74.32
Accounts Receivable, 1 Yr. Growth %	29.34	7.98	-36.39	38.77	5.19
Inventory, 1 Yr. Growth %	-3.82	13.6	-13.38	17.65	-21.96
Net Property, Plant and Equip., 1 Yr. Growth %	-3.78	-7.75	-3.94	23.98	4.02
Total Assets, 1 Yr. Growth %	-1.93	2.8	-10.82	8.84	-9.32
Tangible Book Value, 1 Yr. Growth %	-2.96	-1.99	-5.07	4.42	-5.85
Common Equity, 1 Yr. Growth %	-3.17	-2.22	-5.18	4.42	-5.85
Cash From Operations, 1 Yr. Growth %	0.02	5.9	141.82	-51.67	28.38
Capital Expenditures, 1 Yr. Growth %	86.35	-60.94	18.82	864.73	-54.67
Levered Free Cash Flow, 1 Yr. Growth %	29.96	13.64	154.61	-108.35	-814.6
Unlevered Free Cash Flow, 1 Yr. Growth %	29.96	13.64	154.61	-108.35	-814.6
Dividend Per Share, 1 Yr. Growth %	0	0	0	0	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-4.38	4.3	3.88	3.05	-4.12
Gross Profit, 2 Yr. CAGR %	-2.24	-0.45	6.95	8.96	-5.01
EBITDA, 2 Yr. CAGR %	-10.4	-16.94	39.74	33.18	-44.24
EBITA, 2 Yr. CAGR %	-1.45	-18.63	54.12	43.64	-52.57
EBIT, 2 Yr. CAGR %	-1.45	-18.63	54.12	43.64	-52.57
Earnings From Cont. Operations, 2 Yr. CAGR %	-1.68	-16.22	50.27	38.8	-49.07
Net Income, 2 Yr. CAGR %	-1.68	-16.22	50.27	38.8	-49.07
Normalized Net Income, 2 Yr. CAGR %	-1.68	-16.22	50.27	38.8	-49.07
Diluted EPS Before Extra, 2 Yr. CAGR %	-1.68	-16.22	50.27	38.8	-49.07
Accounts Receivable, 2 Yr. CAGR %	1.51	18.18	-17.12	-6.04	20.82
Inventory, 2 Yr. CAGR %	6.8	4.53	-0.8	0.95	-4.18
Net Property, Plant and Equip., 2 Yr. CAGR %	-5.97	-5.78	-5.86	9.13	13.56
Total Assets, 2 Yr. CAGR %	-0.13	0.41	-4.25	-1.48	-0.66
Tangible Book Value, 2 Yr. CAGR %	-1.05	-2.48	-3.54	-0.44	-0.85
Common Equity, 2 Yr. CAGR %	-1.27	-2.69	-3.71	-0.49	-0.85
Cash From Operations, 2 Yr. CAGR %	15.77	-2.45	60.02	8.11	-21.23
Capital Expenditures, 2 Yr. CAGR %	19.24	-14.68	-31.88	238.57	109.12
Levered Free Cash Flow, 2 Yr. CAGR %	29.53	21.53	70.1	-53.89	-22.76
Unlevered Free Cash Flow, 2 Yr. CAGR %	29.53	21.53	70.1	-53.89	-22.76
Dividend Per Share, 2 Yr. CAGR %	41.42	0	0	0	0
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-4.96	-1	3.42	4.07	-2.22
Gross Profit, 3 Yr. CAGR %	-1.02	-0.82	3.56	6.62	0.37
EBITDA, 3 Yr. CAGR %	-4.52	-3.86	6.76	25.22	-18.14
EBITA, 3 Yr. CAGR %	5.18	3.59	11.17	33.16	-22.42
EBIT, 3 Yr. CAGR %	5.18	3.59	11.17	33.16	-22.42
Earnings From Cont. Operations, 3 Yr. CAGR %	4.53	4.59	10.23	31.62	-20.91
Net Income, 3 Yr. CAGR %	4.53	4.59	10.23	31.62	-20.91
Normalized Net Income, 3 Yr. CAGR %	4.53	4.59	10.23	31.62	-20.91
Diluted EPS Before Extra, 3 Yr. CAGR %	4.53	4.59	10.23	31.62	-20.91
Accounts Receivable, 3 Yr. CAGR %	5.35	3.63	-3.87	-1.58	-2.44
Inventory, 3 Yr. CAGR %	3.98	9.02	-1.82	5	-7.35
Net Property, Plant and Equip., 3 Yr. CAGR %	-8	-6.56	-5.17	3.19	7.4
Total Assets, 3 Yr. CAGR %	-0.39	0.84	-3.48	-0.07	-4.17
Tangible Book Value, 3 Yr. CAGR %	-0.15	-1.37	-3.35	-0.96	-2.27
Common Equity, 3 Yr. CAGR %	-0.38	-1.59	-3.53	-1.07	-2.31
Cash From Operations, 3 Yr. CAGR %	10.78	8.44	32.02	7.37	14.48
Capital Expenditures, 3 Yr. CAGR %	-12.94	-17.8	-4.73	64.82	73.2
Levered Free Cash Flow, 3 Yr. CAGR %	70.26	24	55.5	-37.72	14.95
Unlevered Free Cash Flow, 3 Yr. CAGR %	70.26	24	55.5	-37.72	14.95
Dividend Per Share, 3 Yr. CAGR %	-	25.99	0	0	0
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-2.72	-1.04	-1.52	0.6	0.34
Gross Profit, 5 Yr. CAGR %	-2.25	1.52	2.09	2.98	0.04
EBITDA, 5 Yr. CAGR %	-11.19	-1.19	11.19	9.53	-17.67
EBITA, 5 Yr. CAGR %	-7.81	7.09	22.55	18.06	-20.93
EBIT, 5 Yr. CAGR %	-7.81	7.09	22.55	18.06	-20.93
Earnings From Cont. Operations, 5 Yr. CAGR %	-5.01	6.47	20.86	17.12	-19.06
Net Income, 5 Yr. CAGR %	-5.01	6.47	20.86	17.12	-19.06
Normalized Net Income, 5 Yr. CAGR %	-7.57	6.47	20.86	17.12	-19.06
Diluted EPS Before Extra, 5 Yr. CAGR %	-5.01	6.47	20.86	17.12	-19.06
Accounts Receivable, 5 Yr. CAGR %	-7.39	3.89	-4.29	-0.36	5.34
Inventory, 5 Yr. CAGR %	2.69	7.5	2.04	5.72	-2.77
Net Property, Plant and Equip., 5 Yr. CAGR %	-8.76	-7.99	-7.15	-0.58	1.92
Total Assets, 5 Yr. CAGR %	-1.17	1.66	-1.95	-0.1	-2.36
Tangible Book Value, 5 Yr. CAGR %	-1.3	0.32	-1.52	-1	-2.36
Common Equity, 5 Yr. CAGR %	-1.25	0.35	-1.73	-1.15	-2.46
Cash From Operations, 5 Yr. CAGR %	-11.66	-13.54	25.62	8.31	7.38
Capital Expenditures, 5 Yr. CAGR %	-11.92	-14.79	-21.07	44.8	30.48
Levered Free Cash Flow, 5 Yr. CAGR %	4.89	-16.46	70.19	-16.53	17.54
Unlevered Free Cash Flow, 5 Yr. CAGR %	4.81	-16.46	70.19	-16.53	17.54
Dividend Per Share, 5 Yr. CAGR %	0	-10.07	-	14.87	0